The nation’s attorneys general determine NAAG’s legislative agenda through an endorsement letter process. Â
 Through NAAG endorsement letters, attorneys general:Â
- Provide invaluable insight to the federal government. Â
- Voice their support or dissent for federal legislation and policy. Â
- Communicate recommendations or requests to industry groups or companies.Â
For NAAG to endorse a legislative initiative or a specific piece of legislation, a bipartisan group of at least 36 attorneys general must submit their approval. While NAAG is a nonpartisan organization, it engages in policy advocacy only when an issue has bipartisan support from a majority of attorneys general.Â
Explore recent NAAG policy letters below or learn about other NAAG advocacy initiatives.Â
Search
Topic
States / Territories
Publication Year
NAAG Endorses the FIGHT Act
This legislation is crucial to federal and state efforts to curb the opioid epidemic nationally and within each individual state. It is for these reasons that we commend Senators Portman and Manchin for their leadership in bringing forward this important legislation, and we urge you to take up and pass S. 2701 before the DEA’s temporary order expires.
Attorneys General Urge Senate to Support Veterans by Passing the Veteran Treatment Court Coordination Act
We urge the Senate to further support this important court program. H.R. 886 would establish a Veteran Treatment Court Program in the Department of Justice to provide grants and technical assistance to state, local and tribal courts that implement Veterans Treatment Courts. As Attorneys General, we strongly support this important program in our courts and encourage the continued support of the Congress for our nation’s veterans.
NAAG Endorses Autism CARES Act of 2019
ASD impacts hundreds of thousands of Americans. Congress began addressing autism in 2000 with the first enactment of the bill. The 161 cosponsors of the current House and Senate bills and the 118+ bipartisan members of the Congressional Coalition for Autism Research and Education demonstrate its significance. The Autism CARES Act of 2019 will continue Congress’ ongoing mission to ensure that those living with ASD receive the necessary support and research. Therefore, we, the undersigned attorneys general, ask you to support and to enact the Autism Cares Act of 2019 before September 30, 2019.
AGs Send Policy Guidelines to Streaming Industry to Combat Youth Tobacco Use
Given the recent significant rise in tobacco use by young people, particularly the use of e-cigarettes, preventing initiation and use of tobacco products is of critical importance to us and the public health community, and we sincerely hope it will be addressed by the streaming industry.
NAAG Requests Removal of Federal Barriers to Treat Opioid Use Disorder
Unfortunately, there are three significant barriers to treating opioid use disorder that we cannot change at the state level and that must be tackled at the federal level. We share these barriers below in the hope that we can work together to remove them and allow more providers to offer treatment for opioid use disorder and other substance use disorders.
NAAG Urges FDA to Include AGs in Oversight of Cannabis-Derived Products
As the primary enforcers of our respective states’ consumer protection laws, we offer a unique perspective as to the new legalized market of certain cannabis and cannabis-derived compounds, including CBD products. We write to express our hope that the FDA continues to explore manufacturing, testing, and marketing best practices so that consumers are not at risk of misleading advertising or harm to their health from dangerous additives or undisclosed risks of use. Although products containing cannabis or cannabis-derived compounds may well offer real benefits to consumers, it is important that consumers have reliable risk and benefit information to make informed choices about initiating and continuing the use of these products. A crucial element of FDA regulation and oversight should be an on-going assessment of the potential risks or benefits of these products, particularly for specific populations such as pregnant women, adolescents and children, and the elderly. How these products interact with other dietary or pharmaceutical products should be included in this assessment. It is also important that companies not mislead consumers. Scientific and medical data from the FDA would assist in meaningful enforcement of advertising laws and regulations by the states.
AGs Submit Comments to FTC for Hearings on Competition and Consumer Protection in the 21st Century
Forty-three state and territory attorneys general submitted comments to the Federal Trade Commission (FTC) Hearings on Competition and Consumer Protection in the 21st Century.
NAAG Asks Department of Education to Discharge Loans of Disabled Veterans
We write, as the Attorneys General of our jurisdictions, to urge the Department of Education to take prompt action to satisfy its statutory mandate to discharge the student loans of veterans who are permanently and totally disabled or otherwise unemployable. As a nation, we have a moral obligation to assist those who have put their lives on the line to defend us.
State AGs Support Amendment to Communications Decency Act
In 2013 and again in 2017, Attorneys General from virtually every state and territory wrote to inform Congress of a damaging misinterpretation and misapplication of Section 230 of the Communications Decency Act of 1996 (CDA) that rendered state and local authorities unable to enforce criminal laws against companies that actively profited from the promotion and facilitation of sex trafficking and crimes against children. To be sure, we are grateful for all the work you have done to protect the vulnerable among us. To bootstrap your efforts, we renew our recommendation for a modest but necessary amendment to the CDA. We must enable our state and local authorities to protect our citizens, including the most vulnerable among us, and to take appropriate action against criminal actors.
